Immunosensors Based on Nanomaterials for Detection of Tumor Markers

Journal of Biomedical Nanotechnology
Yuxuan LaiSong Li

Abstract

Nanomaterials have been widely used to immobilize biomolecules, amplify the signals and concentrate the analytes for detection with good properties including large surface area, good adsorption capacity and high surface activity. In recent years, nanomaterials such as carbon nanomaterials, noble metal nanomaterials, polymers, are widely applied to research and develop immunosensors with high sensitivity and selectivity, which monitor the antigen-antibody reaction for the detection of tumor markers. This review provides an introduction of immunosensors and focuses on the design of electrochemical (EC) immunosensors, electrochemical luminscence (ECL) immunosensors and photoelectrochemical (PEC) immunosensors based on nanomaterials in nearly three years.

Related Concepts

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.